High-Altitude Pulmonary Edema: The Disguised Killer

Area of Science:

• Environmental Medicine
• Pulmonary Medicine
• Altitude Physiology

Background:

• High-altitude pulmonary edema (HAPE) affects 1-2% of individuals ascending above 10,000-11,000 ft.
• HAPE represents a severe manifestation of altitude-related illnesses, with symptoms ranging from subtle to overt.
• Rapid progression to coma and death is possible if untreated.

Purpose of the Study:

• To review the signs, symptoms, and recognition of HAPE.
• To discuss the underlying pathophysiology of HAPE.
• To outline strategies for the prevention and management of HAPE.

Main Methods:

• Literature review of high-altitude illnesses, focusing on HAPE.
• Analysis of clinical presentations and progression of HAPE.
• Synthesis of current knowledge on HAPE pathophysiology, prevention, and treatment.

Main Results:

• HAPE symptoms can be subtle or overt and progress rapidly.
• Acclimatization, involving slow ascent, is the primary preventive measure.
• Understanding pathophysiology aids in recognizing and managing HAPE.

Conclusions:

• HAPE is an avoidable but potentially fatal condition.
• Recognizing early signs and symptoms is crucial for timely intervention.
• Effective prevention and management rely on proper acclimatization and prompt treatment.